Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Shah Pratik

SEC-identified person · CIK 1580787 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Silverback Therapeutics, Inc. SPRY Director filed 2022 - 2026
Design Therapeutics, Inc. DSGN Director · President, CEO and Chairperson filed 2021 - 2026
Synthorx, Inc. THOR Director filed 2018 - 2020
Auspex Pharmaceuticals, Inc. ASPX Director · President and CEO filed 2014 - 2015
Tranzyme INC TZYM Director filed 2013 - 2013

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.